Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections
- 1 August 1996
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 7 (3) , 193-202
- https://doi.org/10.1016/s0924-8579(96)00319-6
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumoniaCritical Care Medicine, 1995
- Viral Respiratory InfectionsPediatric Clinics of North America, 1994
- Antiviral Portrait Series: 4. Polysuifates as Inhibitors of HIV and Other Enveloped VirusesAntiviral Chemistry and Chemotherapy, 1994
- High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infectionThe Journal of Pediatrics, 1994
- Mixed viral infections: detection and managementClinical Microbiology Reviews, 1994
- Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infectionThe Pediatric Infectious Disease Journal, 1993
- Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteinsAntimicrobial Agents and Chemotherapy, 1991
- A Controlled Trial of Aerosolized Ribavirin in Infants Receiving Mechanical Ventilation for Severe Respiratory Syncytial Virus InfectionNew England Journal of Medicine, 1991
- Early ribavirin treatment of respiratory syncytial viral infection in high-risk childrenThe Journal of Pediatrics, 1990
- What is the Clinical Role of Aerosolized Ribavirin?DICP, 1990